![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Melissa Mitchell, News Editor
melissa@uiuc.edu
217-333-5491
University of Illinois at Urbana-Champaign
Caption: Research by Kenneth Watkin may lead to the development of a new breed of “multimodal” contrast agents that could work within a host of medical imaging platforms -- from ultrasound and computed tomography (CT) to magnetic resonance imaging and molecular imaging. In the screen above, right, is a high-resolution scanning transmission electron microscope image of dextran small particulate gadolinium oxide (SPGO), showing the core Gd2O3 nanoparticle. At left, is an electron diffraction pattern of dextran SPGO.
Credit: Photo by L. Brian Stauffer
Usage Restrictions: None
Related news release: New contrast agents may be on horizon for better medical imaging
|